Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Samaneh Tanhapour"'
Autor:
Mohammad Effatpanah, Amin Nakhostin-Ansari, Fateme Gorgani, Samaneh Tanhapour Khotbehsara, Shakiba Seifi, Hadis Nasoori, Amir Hossein Memari, Seyed Reza Darijani
Publikováno v:
Balkan Medical Journal, Vol 41, Iss 2, Pp 121-129 (2024)
Background: Previous studies have mainly focused on individual mental disorders, and there is no study addressing the total burden of mental disorders in the Middle East and North Africa (MENA). Aims: To evaluate the burden of mental disorders in th
Externí odkaz:
https://doaj.org/article/c4e5df760ad94a5d8a4f6a02d37d2ff8
Publikováno v:
Journal of Advanced Biomedical Sciences, Vol 13, Iss 1, Pp 23-28 (2023)
Background & Objectives: EOS, as a new imaging technique, has several benefits over conventional radiography in measuring spinal curvatures. In this study, we aimed to use EOS to determine the normal values of thoracic kyphosis besides its associa
Externí odkaz:
https://doaj.org/article/f060e8a30d6d45f099ec89994684bd7b
Autor:
Parisa Dini, Soheila Aminimoghaddam, Zahra Mirzaasgari, Neda Rahimian, Samaneh Tanhapour Khotbehsara, Meysam Abolmaali
Publikováno v:
BMC Pregnancy and Childbirth, Vol 22, Iss 1, Pp 1-4 (2022)
Abstract Background Coronavirus Disease 2019 (COVID-19) is predominately known as a respiratory disease associated with pneumonia, acute respiratory distress syndrome and multiorgan failure. However, extra-pulmonary complications of severe acute resp
Externí odkaz:
https://doaj.org/article/e10e45134ed24109b2355f6ba2de3474
Autor:
Seyed Farzad Maroufi, Fereshteh Naderi Behdani, Fatemeh Rezania, Samaneh Tanhapour Khotbehsara, Zahra Mirzaasgari
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/af6466f6fce448c5b4615addd02c0549
Autor:
Sara Esmaeili, Mohammad Hossein Abbasi, Meysam Abolmaali, Mohammad Mojtahed, Seyedeh Niloufar Rafiei Alavi, Sevim Soleimani, Mahisa Mokhtari, Jaber Hatam, Samaneh Tanhapour Khotbehsara, Mohammad Reza Motamed, Mohammad Taghi Joghataei, Zahra Mirzaasgari, Mehdi Moghaddasi
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Choosing a safe disease modifying therapy during the COVID-19 pandemic is challenging. This case series study was conducted to determine the incidence rate and the course of Covid-19 infection in MS/NMOSD patients treated with Rit
Externí odkaz:
https://doaj.org/article/2c26e27b4d8644f59b1632c651e34464
Autor:
Seyed Farzad Maroufi, Fereshteh Naderi Behdani, Fatemeh Rezania, Samaneh Tanhapour Khotbehsara, Zahra Mirzaasgari
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)
Mass vaccination has been the main policy to overcome the Covid-19 pandemic. Several vaccines have been approved by the World Health Organization. With growing vaccination, safety concerns and adverse events that need prompt evaluation are also emerg
Externí odkaz:
https://doaj.org/article/02614392fb494ced8cf25d4466aae57c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mohammad Hossein Abbasi, Sara Esmaeili, Seyedehnarges Tabatabaee, Fatemeh Sheibani, Mahdi Saberi Pirouz, Mohammad Taghi Joghataei, Mahisa Mokhtari, Seyedeh Niloufar Rafiei Alavi, Keihan Mostafavi, Samaneh Tanhapour khotbehsara, Fateme Siahpoosh, Sevim Soleimani, Jaber Hatam, Zahra Mirzaasgari
Background: Recombinant tissue plasminogen activator (rTPA) is the gold standard therapy for ischemic stroke patients within the appropriate time interval. In addition to its undoubtedly benefits, recognizing its possible adverse effects is of utmost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78a44dc04473e3ff2803fa93d832eb8f
https://doi.org/10.21203/rs.3.rs-1669033/v1
https://doi.org/10.21203/rs.3.rs-1669033/v1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mohammad Hossein Abbasi, Mohammad Taghi Joghataei, Mohammad Reza Motamed, Sevim Soleimani, Meysam Abolmaali, Mohammad Mojtahed, Sara Esmaeili, Jaber Hatam, Mahisa Mokhtari, Seyedeh Niloufar Rafiei Alavi, Samaneh Tanhapour Khotbehsara, Zahra Mirzaasgari, Mehdi Moghaddasi
Publikováno v:
BMC Neurology
BMC Neurology, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Neurology, Vol 21, Iss 1, Pp 1-8 (2021)
Background Choosing a safe disease modifying therapy during the COVID-19 pandemic is challenging. This case series study was conducted to determine the incidence rate and the course of Covid-19 infection in MS/NMOSD patients treated with Rituximab. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38de58ba33612a43864ca4b9435c07d9
https://doi.org/10.1186/s12883-021-02218-4
https://doi.org/10.1186/s12883-021-02218-4